Structure Therapeutics Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

GPCR
Structure Therapeutics

Last Price:

$25.63

Seasonality Move:

7.17%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here

Structure Therapeutics Stock Forecast

Over the next 52 weeks, Structure Therapeutics has on average historically risen by 17.5% based on the past 2 years of stock performance.
Structure Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Structure Therapeutics Stock Undervalued?

The current Structure Therapeutics [GPCR] share price is $25.57. The Score for GPCR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
GPCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Structure Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Structure Therapeutics has on average historically risen by 17.5% based on the past 2 years of stock performance.

Structure Therapeutics Stock Rating

Sell

Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics overpriced?

Structure Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Structure Therapeutics Stock Price History

Is GPCR stock going to rise?

The current trend is moderately bullish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

structuretx.com

52-Week Data

52-Week High:

62.74

52-Week Low:

13.22

Prediction Charts

Market Cap:

1.5B

Price in USD:

25.57

Volume:

599.3K

Beta:

-1.79

Technical Analysis

SMA50:

21.29

SMA100:

24.15

SMA200:

30.89

52-Wk Change:

-33.84%

Stock Predictions

Is Structure Therapeutics stock public?

Yes, Structure Therapeutics is a publicly traded company.
What is the Structure Therapeutics stock quote today?

The Structure Therapeutics stock price is 25.57 USD today.
How to buy Structure Therapeutics stock online?

You can buy Structure Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-22	23.17	23.04	23.34	21.86
Apr-23	23.57	23.32	24.45	23.05
Apr-24	23.21	23.65	24.00	22.79
Apr-25	23.50	23.74	24.19	23.20
Apr-28	23.74	23.62	24.63	23.61
Apr-29	24.15	25.91	26.25	24.11
Apr-30	25.50	27.00	28.16	25.29
May-1	27.20	27.33	27.80	26.16
May-2	27.98	27.09	28.68	27.02
May-5	26.91	27.55	27.68	26.19
May-6	27.12	25.33	27.78	25.26
May-7	25.52	26.60	26.65	25.06
May-8	26.72	26.82	27.50	25.85
May-9	26.65	25.57	27.12	25.51

Structure Therapeutics Earnings

Structure Therapeutics Earnings Report: Per Share Structure Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Structure Therapeutics Forecast Revenue Growth

Structure Therapeutics Stock Analysis: Historical quarterly revenues per share for Structure Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.06 per share, and a decrease next year of $0.62 per share.

* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.